| Bioactivity | PD-1/PD-L1-IN 5 TFA is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1]. |
| Target | IC50: ≤100 nM (PD-1/PD-L1) |
| Invitro | The compounds modulate PD-1/PD-L1 protein/protein interaction and are useful in the treatment of various diseases including infectious diseases and cancer. The compounds can be used as immunomodulators[1]. |
| Name | PD-1/PD-L1-IN 5 TFA |
| CAS | 2170209-52-4 |
| Formula | C22H18N4O3S.xC2HF3O2 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kaijiong Xiao, et al. Heterocyclic compounds as immunomodulators. WO2017222976A1. |
PD-1/PD-L1-IN 5 TFA
CAS: 2170209-52-4 F: C22H18N4O3S.xC2HF3O2 W:
PD-1/PD-L1-IN 5 TFA is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.